Cargando…

Optimised analysis of tamoxifen and its main metabolites in the plasma and cytosol of mammary tumours.

Recent biochemical and pharmacological findings concerning tamoxifen (TMX) have proven that both the unchanged drug and the main metabolites, N-desmethyltamoxifen (NDT) and 4-hydroxytamoxifen (4OHT) are biologically active. An HPLC method based on on-line post-column UV irradiation with fluorescence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milano, G., Etienne, M. C., Frenay, M., Khater, R., Formento, J. L., Renee, N., Moll, J. L., Francoual, M., Berto, M., Namer, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1987
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001713/ https://www.ncbi.nlm.nih.gov/pubmed/3606944

Ejemplares similares

Tamoxifen metabolism: pharmacokinetic and in vitro study.
por: Etienne, M. C., et al.
Publicado: (1989)

Simultaneous micro measurement of steroid receptors in breast cancer.
por: Milano, G., et al.
Publicado: (1983)

Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil
por: Magné, N, et al.
Publicado: (2003)

Application of an original RT-PCR–ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients
por: Ferrero, J M, et al.
Publicado: (2000)

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
por: Etienne, M C, et al.
Publicado: (1999)

A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.
por: Launay, M. C., et al.
Publicado: (1989)

The influence of tamoxifen on normal mouse mammary gland homeostasis
por: Shehata, Mona, et al.
Publicado: (2014)

Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients
por: Ximenez, João Paulo Bianchi, et al.
Publicado: (2019)

Continuous 5-day regional chemotherapy by 5-fluorouracil in colon carcinoma: pharmacokinetic evaluation.
por: Boublil, J. L., et al.
Publicado: (1985)

Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.
por: Bernard, S., et al.
Publicado: (1991)

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity
por: Etienne, M-C, et al.
Publicado: (2004)

Molecular Action of Tamoxifen in the Ovaries of Rats with Mammary Neoplasia
por: Nynca, Anna, et al.
Publicado: (2023)

Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines
por: Fischel, J-L, et al.
Publicado: (2001)

Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity
por: Fischel, J L, et al.
Publicado: (2002)

Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites
por: Jager, Nynke GL, et al.
Publicado: (2013)

Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS.
por: Baluch, S., et al.
Publicado: (1991)

Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.
por: Pace, P., et al.
Publicado: (1997)

Epidermal growth factor receptor double targeting by a tyrosine kinase inhibitor (Iressa) and a monoclonal antibody (Cetuximab). Impact on cell growth and molecular factors
por: Fischel, J-L, et al.
Publicado: (2005)

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.
por: Etienne, M. C., et al.
Publicado: (1991)

Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours
por: MacCallum, J, et al.
Publicado: (2000)

Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients.
por: Lien, E. A., et al.
Publicado: (1991)

Effects of Ginkgo biloba on chemically-induced mammary tumors in rats receiving tamoxifen
por: Dias, Marcos Correa, et al.
Publicado: (2013)

Influence of Tamoxifen on Different Biological Pathways in Tumorigenesis and Transformation in Adipose-Derived Stem Cells, Mammary Cells and Mammary Carcinoma Cell Lines—An In Vitro Study
por: Schlottmann, Frederik, et al.
Publicado: (2022)

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer
por: Woo, Hye In, et al.
Publicado: (2017)

In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control
por: Felker, Anastasia, et al.
Publicado: (2016)

Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development
por: Ford, Benjamin M., et al.
Publicado: (2016)

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment
por: Lien, Ernst A., et al.
Publicado: (2013)

Effect of different exogenous fatty acids on the cytosolic triacylglycerol content in bovine mammary cells
por: Vargas-Bello-Pérez, Einar, et al.
Publicado: (2019)

Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
por: Chen, Yuanhuang, et al.
Publicado: (2021)

Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes
por: Hattar, Rhonda, et al.
Publicado: (2009)

Therapeutic Effects of a Traditional Chinese Medicine Formula Plus Tamoxifen vs. Tamoxifen for the Treatment of Mammary Gland Hyperplasia: A Meta-Analysis of Randomized Trials
por: Li, Hao-Tian, et al.
Publicado: (2018)

Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review
por: Hind, D, et al.
Publicado: (2007)

Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells
por: Palaniappan, Murugesan, et al.
Publicado: (2018)

Modeling Mammary Cancer in Mice Conference, Jackson Laboratory, Bar Harbor, Maine, 5-8 October, 1999
por: Murphy, Kristen L, et al.
Publicado: (2000)

The formation of estrogen-like tamoxifen metabolites and their influence on enzyme activity and gene expression of ADME genes
por: Johänning, Janina, et al.
Publicado: (2017)

Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol
por: Beers, Jessica L., et al.
Publicado: (2023)

Use of antipsychotics with tamoxifen
por: Ghabi, H., et al.
Publicado: (2021)

Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Cancer by Miso and Tamoxifen, Alone and in Combination
por: Gotoh, Takahiko, et al.
Publicado: (1998)

Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system
por: Beh, Chaw Yee, et al.
Publicado: (2019)

Tamoxifen decreases ovarian toxicity without compromising cancer treatment in a rat model of mammary cancer
por: Nynca, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_phjtdjlqstr4c0eq8f9fjni1vv